Thursday, February 6, 2025 • 4:45 p.m.-9:30 p.m.

Hilton East Brunswick

Register Today!
Become a Sponsor

Considered the kickoff event of the year for the life sciences industry in New Jersey, BioNJ's 32nd Annual Dinner Meeting & Innovation Celebration will bring hundreds of biopharma professionals, academic leaders, Patients, advocates and service providers together to honor the groundbreaking medical innovation coming from the Garden State.

 

"Because Patients Can't Wait®, we are incredibly proud of our Members who are helping Patients live longer, better lives," said BioNJ President and CEO Debbie Hart. "At BioNJ's Annual Dinner Meeting & Innovation Celebration, we'll come together to honor the remarkable dedication and transformative work of New Jersey's life sciences community — a beacon of innovation and hope that turns Patients' dreams into reality around the globe. With 21 novel FDA approvals in 2024, New Jersey proudly stands at the forefront of progress, setting the standard for excellence across the nation."


The 2025 Innovator Award Honorees Include:

  • Ascendis Pharma for the approval of Yorvipath®
  • BeiGene for the approval of Tevimbra®
  • Bristol Myers Squibb for the approval of Cobenfy™
  • Bracco Diagnostics for the approval of Iomervu®
  • Citius Pharmaceuticals for the approval of Lymphir™
  • Eli Lilly for the approvals of Ebglyss™ and Kisunla™
  • Idorsia for the approval of Tryvio™
  • Ipsen for the approval of Iqirvo™
  • Galderma for the approval of Nemluvio®
  • GE HealthCare for the approval of Flyrcado™
  • Geron for the approval of Rytelo™
  • Gilead for the approval of Livdelzi®
  • Johnson & Johnson for the approval of Lazcluze™
  • Merck & Co. for the approvals of Capvaxive™ and Winrevair™
  • Novo Nordisk for the approval of Alhemo®
  • Pfizer for the approvals of Beqvez™ and Hympavzi™
  • PTC Therapeutics for the approval of Kebilidi™
  • Sun Pharma for the approval of Leqselvi™


Additionally, the inspirational evening will include the presentation of the Dr. Sol J. Barer Award for Vision, Innovation and Leadership by Dr. Barer himself to Chief Patient Advocate for Amicus Therapeutics Jayne Gershkowitz; the presentation of the Heart of BioNJ Awards recognizing extraordinary Patient Advocates; the opportunity to network with the "Who's Who" of the industry; an inspirational presentation by 16-year-old Patient Advocate and brain cancer survivor Grace Eline; a closing fireside chat with President and CEO of the Biotechnology Innovation Organization John Crowley and Director of the Center for Biologics Evaluation and Research, U.S. Food and Drug Administration Dr. Peter Marks and non-stop fun with a cocktail reception, dinner program and dessert reception. 


Don't miss this memorable evening celebrating New Jersey's life sciences ecosystem and the Patients who inspire us. Registration for BioNJ Members is $540 and $625 for Future Members. Reserve a table for your Team today. Visit www.BioNJ.org for more information.

Thank You To Our Sponsors

 

Contact Cheri Hennessy at CHennessy@BioNJ.org to learn about Sponsorship Opportunities, reserve a table and to place your organization in the spotlight. 

This promotion was sent by BioNJ.